Latest news with #King'sCollegeHospitalDubai
Khaleej Times
25-04-2025
- Health
- Khaleej Times
King's College Hospital London Dubai leads the future of healthcare with AI-powered innovations
King's College Hospital London Dubai is setting a new standard in patient care with the integration of cutting-edge artificial intelligence (AI) technologies, positioning itself as a trailblazer in healthcare innovation across the region. Through the adoption of advanced AI diagnostic and operational solutions, the hospital is enhancing clinical accuracy, optimising workflows, and making world-class medical care more accessible under one roof. King's College Hospital London Dubai has deployed two groundbreaking AI technologies that significantly improve diagnostic precision and streamline clinical processes, reinforcing the hospital's dedication to innovation and excellence. This is only the beginning of this transformation. Breast cancer remains one of the most common cancers among women, and early detection is critical to improving survival rates. AI-powered mammogram analysis utilises deep learning to accurately identify and assess abnormalities, enhancing detection rates by identifying lesions that may be missed in traditional screenings. By integrating this AI solution into its radiology services, King's College Hospital has set a new benchmark for precision in breast cancer diagnostics, ensuring earlier intervention and more effective treatment planning. King's College Hospital Dubai is also the first in the UAE to introduce Ambient Clinical Voice technology — an advanced AI solution that is redefining clinical documentation. Ambient Clinical Voice, or ambient listening, is a secure, AI-powered medical assistant that passively listens during consultations, capturing the nuances of doctor-patient conversations in real time. Using advanced natural language processing, it intelligently interprets medical dialogue, context, and intent to generate accurate clinical notes tailored to each physician's documentation style and specialty. These notes are seamlessly integrated into the patient's electronic health record, ready for review and sign-off with minimal edits. By eliminating the need for manual note-taking, Ambient Clinical Voice allows physicians to engage more meaningfully with their patients —reducing cognitive load, improving documentation quality, and enhancing overall care delivery. It's a quiet but powerful presence in the room, supporting clinicians without disrupting the human connection at the heart of healthcare. Chief digital and innovation officer, Sandip Kumar, emphasised the hospital's commitment to transformative care: "At King's, we believe that innovation is not just about adopting new technologies but about ensuring these advancements directly benefit our patients. By integrating AI-driven solutions, we are revolutionising diagnostics and operational efficiency. Our vision is to enhance accuracy, improve early disease detection, and enable our clinicians to dedicate more time to patient care. These advancements are just the beginning, as we continue to push the boundaries of what's possible in modern healthcare." CEO Kimberley Pierce reaffirmed King's mission to stay at the forefront of innovation: "Healthcare is evolving rapidly, and King's is leading the charge in embracing the latest AI technologies to enhance diagnostics, streamline clinical operations, and improve patient outcomes. Our commitment is to provide world-class healthcare that is not only advanced but also patient-centric. These new AI-driven solutions are just the beginning of our ambitious roadmap for the future of healthcare in the region."
Arab Times
17-04-2025
- Health
- Arab Times
First-of-its-kind treatment offers a new lease on life for the youngest Parkinson's patient in the UAE and MENA region.
In a remarkable advancement in medical care, King's College Hospital London in Dubai has successfully administered the subcutaneous Levodopa (Fos-levodopa) pump treatment to the youngest Parkinson's patient in the UAE and the broader Middle East, North Africa (MENA), and GCC regions. Diagnosed with Parkinson's disease at just 30 years old, the patient has been battling the condition for 14 years and previously relied on continuous support from three caregivers. This groundbreaking treatment marks a significant milestone in Parkinson's care, offering renewed hope and a notable improvement in the patient's quality of life. As one of the leading facilities for advanced neurological and Parkinson's care in the region, King's College Hospital Dubai is proud to be among the first to offer the Foslevodopa pump—an innovative next-generation treatment for advanced Parkinson's disease. This procedure delivers levodopa, the gold standard in Parkinson's treatment, continuously through the skin, similar to an insulin pump used for diabetes management. The treatment is personalized to meet the individual needs of each patient, with medication doses adjusted by experienced Parkinson's specialists such as Dr. Vinod Metta and Prof. Ray Chaudhuri. The new solution transforms Parkinson's care in the UAE, enabling patients to regain their independence and participate in daily activities, such as fasting during Ramadan, after years of struggle. "Personalized care and tailored dosage are essential in Parkinson's treatment, as each patient's condition is unique. It is important to optimize the dosage based on disease severity and the patient's dopamine requirements. With device-assisted therapies like the Foslevodopa pump, patients can take control of their condition. Watching our patient regain independence, enjoy a meal on his own, and walk unaided is a powerful testament to the positive impact this new treatment can have on individuals' lives." The procedure was carried out at the Parkinson's Centre of Excellence at King's College Hospital London in Dubai, a regional leader in movement disorder care. The center is dedicated to offering world-class diagnostics, treatment innovations, and multidisciplinary support to Parkinson's patients and their families, ensuring holistic, patient-centered care. Professor Ray Chaudhuri, Professor of Neurology and Movement Disorders at King's College Hospital London, highlighted the significance of this breakthrough: "This is a transformative moment for Parkinson's care in the region. Introducing Foslevodopa at King's Dubai represents a major leap forward in personalized therapy, ensuring patients receive optimal care. This groundbreaking breakthrough further reinforces King's commitment to being at the forefront of neurological advancements." King's Parkinson's Centre of Excellence: Leading the Future of Parkinson's Care * A Centre of Excellence for Parkinson's Disease in Dubai/UAE * World-renowned UK-trained Parkinson's specialists, led by Dr. Vinod Metta and Prof. Ray Chaudhuri * Bespoke and tailored approaches, supported by a multidisciplinary team of specialists, including Parkinson's nurses, physiotherapists, speech therapists, dieticians, neuroradiologists, and occupational therapists * King's Parkinson's Centre of Excellence in Dubai started with just one patient under Dr. Vinod Metta's leadership and has since grown into a well-known tertiary referral center in the UAE, Middle East, and MENA, treating over 1,000 Parkinson's patients across the GCC For more information about the Foslevodopa/Foscarbidopa pump treatment, please contact King's Parkinson's Centre of Excellence. Our Parkinson's Nurse Specialist will be happy to assist with any inquiries: * Ms. Therese Masagnay: [email protected] * Ms. Clarissa Sanglian: Clarissa
Khaleej Times
07-04-2025
- Health
- Khaleej Times
Dubai unveils new Parkinson's Pump at King's College Hospital London in Dubai
First-of-its-kind treatment offers a new lease on life for the youngest Parkinson's patient in the UAE and Mena region In a remarkable advancement in medical care, King's College Hospital London in Dubai has successfully administered the subcutaneous Levodopa (Fos-levodopa) pump treatment to the youngest Parkinson's patient in the UAE and the broader Middle East, North Africa (MENA), and GCC regions. Diagnosed with Parkinson's disease at just 30 years old, the patient has been battling the condition for 14 years and previously relied on continuous support from three caregivers. This groundbreaking treatment marks a significant milestone in Parkinson's care, offering renewed hope and a notable improvement in the patient's quality of life. As one of the leading facilities for advanced neurological and Parkinson's care in the region, King's College Hospital Dubai is proud to be among the first to offer the Foslevodopa pump - an innovative next-generation treatment for advanced Parkinson's disease. This procedure delivers levodopa, the gold standard in Parkinson's treatment, continuously through the skin, similar to an insulin pump used for diabetes management. The treatment is personalized to meet the individual needs of each patient, with medication doses adjusted by experienced Parkinson's specialists such as Dr. Vinod Metta and Prof. Ray Chaudhuri. The new solution transforms Parkinson's care in the UAE, enabling patients to regain their independence and participate in daily activities - such as fasting during Ramadan - after years of struggle. Dr Vinod Metta, Consultant Interventional Neurologist & Parkinson's Specialist at King's College Hospital London, Dubai, expressed his thoughts on the successful treatment: "Personalised care and tailored dosage are essential in Parkinson's treatment, as each patient's condition is unique. It is important to optimize the dosage based on disease severity and the patient's dopamine requirements. With device-assisted therapies like the Foslevodopa pump, patients can take control of their condition. Watching our patient regain independence, enjoy a meal on his own, and walk unaided is a powerful testament to the positive impact this new treatment can have on individuals' lives." The procedure was carried out at the Parkinson's Centre of Excellence at King's College Hospital London in Dubai, a regional leader in movement disorder care. The center is dedicated to offering world-class diagnostics, treatment innovations, and multidisciplinary support to Parkinson's patients and their families, ensuring holistic, patient-centered care. Professor Ray Chaudhuri, Professor of Neurology and Movement Disorders at King's College Hospital London, highlighted the significance of this breakthrough: "This is a transformative moment for Parkinson's care in the region. Introducing Foslevodopa at King's Dubai represents a major leap forward in personalized therapy, ensuring patients receive optimal care. This groundbreaking breakthrough further reinforces King's commitment to being at the forefront of neurological advancements." King's Parkinson's Centre of Excellence: Leading the Future of Parkinson's Care ● A Centre of Excellence for Parkinson's Disease in Dubai/UAE ● World-renowned UK-trained Parkinson's specialists, led by Dr. Vinod Metta and Prof. Ray Chaudhuri ● Bespoke and tailored approaches, supported by a multidisciplinary team of specialists, including Parkinson's nurses, physiotherapists, speech therapists, dieticians, neuroradiologists, and occupational therapists ● King's Parkinson's Centre of Excellence in Dubai started with just one patient under Dr. Vinod Metta's leadership and has since grown into a well-known tertiary referral center in the UAE, Middle East, and MENA, treating over 1,000 Parkinson's patients across the GCC For more information about the Foslevodopa/Foscarbidopa pump treatment, please contact King's Parkinson's Centre of Excellence. Our Parkinson's Nurse Specialist will be happy to assist with any inquiries: This advancement represents a significant step forward in improving Parkinson's care and offering hope to patients in the UAE and beyond.
Khaleej Times
29-01-2025
- Health
- Khaleej Times
King's College Hospital Dubai pioneers minimally invasive lung cancer surgery, transforming patient care in the UAE
Lung cancer, a leading cause of cancer-related deaths worldwide, is experiencing a transformative shift in treatment approaches, thanks to advancements in minimally invasive surgical techniques. At the forefront of this evolution is King's College Hospital Dubai, where cutting-edge procedures such as Video-Assisted Thoracoscopic Surgery (VATS), also known as keyhole surgery, are revolutionising lung cancer treatment. By offering these advanced techniques, the hospital is significantly improving patient outcomes, reducing recovery times, and enhancing the overall treatment experience for patients. In the UAE, where risk factors like smoking, exposure to secondhand smoke, and family history contribute to higher lung cancer rates, the need for innovative treatments has never been greater. Lung cancer progresses through four stages, each requiring specialised care: Stage 1, where the cancer is confined to the lungs, is often treated effectively with minimally invasive surgery; Stage 2, where the cancer has spread to nearby lymph nodes, typically involves surgery and chemotherapy; Stage 3 requires a multidisciplinary approach, including chemotherapy, radiation, and occasionally surgery; and Stage 4, the most advanced stage, is managed with targeted therapy, immunotherapy, or palliative care. Keyhole surgery, or VATS, represents a groundbreaking leap in thoracic surgery. By making small incisions in the chest wall and using a thoracoscope— a thin tube equipped with a camera—surgeons can visualise and operate on the lungs without the need for larger incisions or rib spreading, as is common in traditional open surgery. The benefits of this minimally invasive approach are clear: reduced pain, faster recovery, and enhanced comfort for patients. With smaller incisions, there is less trauma to the body, leading to less postoperative pain, shorter hospital stays, and a quicker return to daily activities. Dr James Douglass Aitchison, consultant thoracic surgeon at King's College Hospital Dubai, emphasised the significance of these advancements in lung cancer treatment. "With keyhole surgery, we are revolutionising lung cancer treatment by prioritising patient recovery and comfort. This technique reduces the burden of surgery, allowing patients to focus on their journey to healing with an improved quality of life," he said. VATS is particularly effective for patients with early-stage non-small cell lung cancer (NSCLC). To determine eligibility, comprehensive assessments, including imaging studies and lung function tests, are conducted to ensure patients are suitable candidates for the procedure. The advancements in keyhole surgeries at King's College Hospital Dubai represent a pivotal milestone in the fight against lung cancer. By combining innovative diagnostics, state-of-the-art surgical techniques, and personalised treatment plans, the hospital is setting new standards in patient care. As Dr Aitchison aptly put it, "We're not just treating cancer; we're transforming lives."
